カテゴリ： GlobalData, アメリカ, 企業調査

Hologic Inc (HOLX)：医療機器：M&Aディール及び事業提携情報

◆英語タイトル：Hologic Inc (HOLX) - Medical Equipment - Deals and Alliances Profile
◆商品コード：DATA904C7425
◆発行会社（調査会社）：GlobalData
◆発行日：2018年10月
◆ページ数：79
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Hologic Inc (Hologic) develops, manufactures and supplies diagnostic products, medical imaging systems, surgical products and light-based aesthetic and medical treatment systems. The company offers products to aid in the diagnosis of human diseases; breast imaging and related products and accessories; gynecology surgical products including endometrial ablation system and hysteroscopic tissue removal system; aesthetic laser treatment systems; and skeletal health products including dual-energy X-ray bone densitometry systems and mini C-arm imaging products. The company offers these solutions to surgeons, hospitals, clinical laboratories and healthcare providers. Hologic offers its products and services through direct sales and a network of independent distributors and sales representatives. The company operates in the Americas, Europe and Asia-Pacific. Hologic is headquartered in Marlborough, Massachusetts, the US.

Hologic Inc (HOLX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Hologic Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 7
Hologic Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 8
Hologic Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 9
Hologic Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 10
Hologic Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 11
Hologic Inc, Medical Equipment, Deal Details 13
Asset Purchase 13
Hologic Acquires PCA3 Assets from DiagnoCure for USD4.7 Million 13
Venture Financing 14
Focal Therapeutics Raises USD3.8 Million in Venture Financing 14
Focal Therapeutics Raises USD7.8 Million in Venture Financing 15
Private Equity 16
Percipient Capital Completes Management Buyout Of Elucigene Diagnostics 16
Partnerships 17
MeVis Medical Enters into Licensing Agreement with Hologic 17
Cynosure Enters into Distribution Agreement with Porter Instrument 18
Precision X-Ray and Faxitron Bioptics Form DRMC X-Ray 19
Hologic Enters into Agreement with Royal Philips 20
Hologic Enters into Development and Distribution Agreement with Clarius Mobile Health 21
Faxitron Bioptics Enters into Agreement with Health Beacons 22
Seegene Enters into Agreement with Hologic 23
U.S. Department of Health and Human Services Enters into Agreement with Hologic 24
Bovie Medical Enters into Agreement with Hologic 25
Metamark Genetics Enters into Distribution Agreement with Hologic 26
Metamark Genetics Plans to Enter into Co-Development Agreement with Hologic 27
Cynosure Enters into Co-Marketing Agreement with El.En for MonaLisa Touch 28
Medimaps Enters into Distribution Agreement with Hologic for TBS iNsight 29
Devicor Medical Products Enters Into Distribution Agreement With Faxitron Bioptics For CoreVision 30
Quest Diagnostics Enters Into Co-Development Agreement With Hologic 31
Equity Offering 32
Cynosure Completes Public Offering Of Class A Shares For US$58 Million 32
Debt Offering 33
Hologic Raises USD400 Million in Private Placement of 4.625% Notes Due 2028 33
Hologic Raises USD600 Million in Private Placement of 4.375% Notes Due 2025 34
Hologic Raises USD350 Million in Private Placement of 4.375% Notes Due 2025 35
Hologic Raises USD1 Billion in Private Placement of 5.25% Notes Due 2022 36
Hologic Completes Private Placement Of Senior Notes Due 2020 For US$1 Billion 37
Asset Transactions 38
Grifols Acquires Nucleic Acid Testing Donor Screening Unit from Hologic for USD1.85 Billion 38
Immucor Completes Acquisition Of Lifecodes Business Of Hologic For US$95 Million 40
Acquisition 42
Hologic to Acquire Focal Therapeutics for USD125 Million 42
Hologic Acquires Faxitron Bioptics for USD85 Million 43
Hologic Acquires Cynosure in Tender Offer 44
Cynosure Acquires Ellman International for USD13 Million 46
Cynosure Completes Acquisition Of Palomar Medical Technologies For US$287 Million 47
Hologic Completes Acquisition Of Gen-Probe For US$3.7 Billion 49
Hologic Inc – Key Competitors 51
Hologic Inc – Key Employees 52
Hologic Inc – Locations And Subsidiaries 53
Head Office 53
Other Locations & Subsidiaries 53
Affiliate 56
Recent Developments 57
Strategy And Business Planning 57
Sep 27, 2018: Hologic to buy Focal Therapeutics for $125m 57
Financial Announcements 58
Jul 31, 2018: Hologic Announces Financial Results for Third Quarter of Fiscal 2018 58
May 02, 2018: Hologic Announces Financial Results for Second Quarter of Fiscal 2018 59
Feb 08, 2018: Hologic Announces Financial Results for First Quarter of Fiscal 2018 61
Jan 08, 2018: Hologic Preliminary Revenues Increase 8% to Approximately $791 Million in the First Quarter of Fiscal 2018 63
Nov 08, 2017: Hologic Announces Financial Results for Fourth Quarter of Fiscal 2017 64
Aug 02, 2017: Hologic Announces Financial Results for Third Quarter of Fiscal 2017 66
May 10, 2017: Hologic Announces Financial Results for Second Quarter of Fiscal 2017 68
Feb 01, 2017: Hologic Announces Financial Results for First Quarter of Fiscal 2017 69
Corporate Communications 71
Jul 31, 2018: Hologic Announces Chief Financial Officer Change 71
Jan 11, 2018: Namal Nawana Elected to Hologic Board of Directors 72
May 16, 2017: Charles J. Dockendorff Elected to Hologic Board of Directors 73
Jan 04, 2017: Hologic Appoints President of EMEA and Canada, Completing International Leadership Team 74
Legal and Regulatory 75
Aug 01, 2018: US judge finds Fujifilm infringed on Hologic’s mammography patents 75
Product News 76
Apr 27, 2018: Leading Women’s Health Company Hologic Features Its Innovative Suite of Products at 2018 American College of Obstetricians and Gynecologists Annual Clinical and Scientific Meeting 76
Mar 01, 2017: Hologic to Showcase Groundbreaking Breast Cancer Screening and Interventional Solutions at European Congress of Radiology 2017 78
Appendix 79
Methodology 79
About GlobalData 79
Contact Us 79
Disclaimer 79

List of Tables
Hologic Inc, Medical Equipment, Key Facts, 2017 2
Hologic Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Hologic Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 7
Hologic Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 8
Hologic Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 9
Hologic Inc, Deals By Market, 2012 to YTD 2018 10
Hologic Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 11
Hologic Acquires PCA3 Assets from DiagnoCure for USD4.7 Million 13
Focal Therapeutics Raises USD3.8 Million in Venture Financing 14
Focal Therapeutics Raises USD7.8 Million in Venture Financing 15
Percipient Capital Completes Management Buyout Of Elucigene Diagnostics 16
MeVis Medical Enters into Licensing Agreement with Hologic 17
Cynosure Enters into Distribution Agreement with Porter Instrument 18
Precision X-Ray and Faxitron Bioptics Form DRMC X-Ray 19
Hologic Enters into Agreement with Royal Philips 20
Hologic Enters into Development and Distribution Agreement with Clarius Mobile Health 21
Faxitron Bioptics Enters into Agreement with Health Beacons 22
Seegene Enters into Agreement with Hologic 23
U.S. Department of Health and Human Services Enters into Agreement with Hologic 24
Bovie Medical Enters into Agreement with Hologic 25
Metamark Genetics Enters into Distribution Agreement with Hologic 26
Metamark Genetics Plans to Enter into Co-Development Agreement with Hologic 27
Cynosure Enters into Co-Marketing Agreement with El.En for MonaLisa Touch 28
Medimaps Enters into Distribution Agreement with Hologic for TBS iNsight 29
Devicor Medical Products Enters Into Distribution Agreement With Faxitron Bioptics For CoreVision 30
Quest Diagnostics Enters Into Co-Development Agreement With Hologic 31
Cynosure Completes Public Offering Of Class A Shares For US$58 Million 32
Hologic Raises USD400 Million in Private Placement of 4.625% Notes Due 2028 33
Hologic Raises USD600 Million in Private Placement of 4.375% Notes Due 2025 34
Hologic Raises USD350 Million in Private Placement of 4.375% Notes Due 2025 35
Hologic Raises USD1 Billion in Private Placement of 5.25% Notes Due 2022 36
Hologic Completes Private Placement Of Senior Notes Due 2020 For US$1 Billion 37
Grifols Acquires Nucleic Acid Testing Donor Screening Unit from Hologic for USD1.85 Billion 38
Immucor Completes Acquisition Of Lifecodes Business Of Hologic For US$95 Million 40
Hologic to Acquire Focal Therapeutics for USD125 Million 42
Hologic Acquires Faxitron Bioptics for USD85 Million 43
Hologic Acquires Cynosure in Tender Offer 44
Cynosure Acquires Ellman International for USD13 Million 46
Cynosure Completes Acquisition Of Palomar Medical Technologies For US$287 Million 47
Hologic Completes Acquisition Of Gen-Probe For US$3.7 Billion 49
Hologic Inc, Key Competitors 51
Hologic Inc, Key Employees 52
Hologic Inc, Other Locations 53
Hologic Inc, Subsidiaries 53
Hologic Inc, Affiliate 56

List of Figures
Hologic Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Hologic Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Hologic Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Hologic Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Hologic Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 7
Hologic Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 8
Hologic Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 9
Hologic Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 10

★海外企業調査レポート[Hologic Inc (HOLX)：医療機器：M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Sun Life Hong Kong Limited：企業の戦略・SWOT・財務分析
    Sun Life Hong Kong Limited - Strategy, SWOT and Corporate Finance Report Summary Sun Life Hong Kong Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Amgen Inc (AMGN)：企業の財務・戦略的SWOT分析
    Amgen Inc (AMGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Mercury NZ：企業の戦略・SWOT・財務情報
    Mercury NZ - Strategy, SWOT and Corporate Finance Report Summary Mercury NZ - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Orsted Salg & Service AS：企業の戦略的SWOT分析
    Orsted Salg & Service AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Mitsubishi Tanabe Pharma Corporation：企業の戦略・SWOT・財務分析
    Mitsubishi Tanabe Pharma Corporation - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Tanabe Pharma Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • EryDel SPA：製薬・医療：M&Aディール及び事業提携情報
    Summary EryDel SPA (EryDel), a subsidiary of Genextra Spa is a drug delivery company that develops drugs and diagnostics delivered through human red blood cells using a proprietary medical device technology. The company’s products include red cell loaders, and disposable kits for drug encapsulation …
  • Automatic Data Processing Inc (ADP)：企業の財務・戦略的SWOT分析
    Automatic Data Processing Inc (ADP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Double Bond Pharmaceutical International AB-製薬・医療分野：企業M&A・提携分析
    Summary Double Bond Pharmaceutical International AB (DBP) is a pharmaceutical company that develops and commercializes treatment of autoimmune diseases, cancers, infections, and other life-threatening disorders. The company’s products include proprietary platforms SA-033, SI-053, SA-042, and SA-083. …
  • Stone Energy Corporation (SGY)-石油・ガス分野：企業M&A・提携分析
    Summary Stone Energy Corporation (Stone Energy) is an independent energy company that carries out the acquisition, exploration, exploitation, development and operation of oil and gas properties in the Gulf of Mexico (GOM). Its portfolio comprises active properties and primary term leases in the GOM …
  • Livzon Pharmaceutical Group Inc (000513)：製薬・医療：M&Aディール及び事業提携情報
    Summary Livzon Pharmaceutical Group Inc (Livzon), a subsidiary of Joincare Pharmaceutical Group Industry Co Ltd, is a pharmaceutical company which is engaged in developing, manufacturing and distributing pharmaceutical products. The company provides preparation drug products, bulk medicines and inte …
  • RHÖN-KLINIKUM AG：企業の戦略・SWOT・財務情報
    RHÖN-KLINIKUM AG - Strategy, SWOT and Corporate Finance Report Summary RHÖN-KLINIKUM AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • New Brunswick Power Corporation：企業の戦略的SWOT分析
    New Brunswick Power Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Janssen Pharmaceuticals Inc：医療機器：M&Aディール及び事業提携情報
    Summary Janssen Pharmaceuticals Inc (Janssen), a subsidiary of Johnson & Johnson is a pharmaceutical company that develops drugs. The company offers medicines for an array of health conditions in therapeutic areas of attention deficit hyperactivity disorder, general medicine, mental health, neurolog …
  • Infant Bacterial Therapeutics AB (IBT B)：企業の財務・戦略的SWOT分析
    Summary Infant Bacterial Therapeutics AB (IBT), a subsidiary of BioGaia AB is a pharmaceutical company that develops drugs influencing the human infant microbiome to treat rare diseases in premature infants. Its pipeline product candidates include IBP-9414, containing the active substance Lactobacil …
  • Bruker Corporation：企業の戦略・SWOT・財務情報
    Bruker Corporation - Strategy, SWOT and Corporate Finance Report Summary Bruker Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Oakdale Electric Cooperative：発電所・企業SWOT分析
    Oakdale Electric Cooperative – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Hemispherx Biopharma Inc (HEB)：製薬・医療：M&Aディール及び事業提携情報
    Summary Hemispherx Biopharma Inc (Hemispherx) is a biopharmaceutical company, which develops, manufactures and commercializes drug therapies for the treatments of viral and immune based chronic disorders. It offers products for the treatment of various diseases such as hepatitis B, hepatitis C, chro …
  • Alibaba Pictures Group Limited：企業のM&A・事業提携・投資動向
    Alibaba Pictures Group Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Alibaba Pictures Group Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Kubota Corporation (6326)：企業の財務・戦略的SWOT分析
    Kubota Corporation (6326) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • PT Dian Swastatika Sentosa Tbk (DSSA)：企業の財務・戦略的SWOT分析
    PT Dian Swastatika Sentosa Tbk (DSSA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆